Orsini announced today that it has been chosen by scPharmaceuticals to distribute FUROSCIX® (furosemide injection)80 mg/10mL for subcutaneous use, indicated for the treatment of congestion due to fluid overload in adults with chronic heart failure. FUROSCIX is a single-use infused diuretic that can be administered at home by patients and caregivers. View the full Prescribing […]

TD Asset Management Inc. (“TDAM”) today announced the October cash distributions for the TD Exchange-Traded Funds (each, a “TD ETF” and collectively, the “TD ETFs”) listed below. Unitholders of record as of October 30, 2024, will receive a cash distribution per unit of the applicable TD ETF that will be payable on November 6, 2024,

VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next generation intelligent systems, today announces the initial results of the Genius(TM) Beta Partner collaboration and the publishing of a paper co-authored by research teams at both Volvo Cars and VERSES.

Reports Plans to Reapply for Nasdaq Listing Announces Progress Advancing Decentralized Cell Processing Platform GERMANTOWN, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare,

Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) — SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn(TM) (iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from CiVi Biopharma. Aurlumyn(TM) will be made available this coming winter season. Arthur Pignot, Chief Strategy Officer at SERB, said:

Westford, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) — Immunohistochemistry Market size was valued at around USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024-2031). Rising use of automation and machine learning in IHC along with the introduction of technically

Austin TX, Oct. 21, 2024 (GLOBE NEWSWIRE) — Texas, mark your calendars–Freebirds World Burrito is celebrating it’s 2nd annual National Freebirds Day on Monday, October 28th. For one day only, guests can indulge in $5.99 burritos, bowls, and salads at all participating Freebirds locations across the Lone Star State. “National Freebirds Day is all about

New York, New York, Oct. 21, 2024 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Solowin Holdings (NASDAQ: SWIN). The in-depth 39-page initiation report includes detailed information on the Solowin’s business model, services, industry overview, valuation, management profile, and risks.

WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it will report results for the third quarter ended September 30, 2024 and provide an update on

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced with deep sadness the passing of former Chairman of the Board of Directors, Ernest Mario, Ph.D, at the age of 86 years. Dr. Mario served